Zenio Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.60 M
as on 13-12-2024
- Paid Up Capital ₹ 0.15 M
as on 13-12-2024
- Company Age 4 Year, 22 Days
- Last Filing with ROC 31 Mar 2023
- Revenue 186.15%
(FY 2023)
- Profit -22.73%
(FY 2023)
- Ebitda -18.93%
(FY 2023)
- Net Worth -162.03%
(FY 2023)
- Total Assets 70.31%
(FY 2023)
About Zenio Biotech
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.60 M and a paid-up capital of Rs 0.15 M, as per Ministry of Corporate Affairs (MCA) records.
Ram Mahajan, Ashish Verma, Naveen Suteri, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24303HR2020PTC091396
- Company No.
091396
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Dec 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Panchkula, Haryana, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Zenio Biotech Private Limited offer?
Zenio Biotech Private Limited offers a wide range of products and services, including Sexual Wellness Products, Fertility Enhancer, Nutraceuticals & Dietary Supplements, Multivitamin Syrup & Drops, Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Hand Sanitizers & Personal Hygiene, Beauty Soap, Ayurvedic,Herbal Products & Medicine, Diabetic Herbal Medicine.
Who are the key members and board of directors at Zenio Biotech?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Naveen Suteri  | Managing Director | 05-Dec-2020 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ram Mahajan | Director | 05-Dec-2020 | Current |
| Ashish Verma | Director | 05-Dec-2020 | Current |
| Richa Chouhan | Director | 05-Dec-2020 | Current |
| Priya Verma | Director | 05-Dec-2020 | Current |
Financial Performance of Zenio Biotech.
Zenio Biotech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 186.15% increase. The company also saw a substantial fall in profitability, with a 22.73% decrease in profit. The company's net worth observed a substantial decline by a decrease of 162.03%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Zenio Biotech?
In 2023, Zenio Biotech had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Iretus Biotech Private LimitedActive 3 years 12 daysRam Mahajan, Ashish Verma and 1 more are mutual person
Nedulix Biotech Private LimitedActive 3 years 19 daysRam Mahajan, Ashish Verma and 1 more are mutual person
Welnex Bio Private LimitedActive 4 years 9 monthsRam Mahajan, Ashish Verma and 1 more are mutual person
- Medplex Biotech Private LimitedActive 2 years 8 months
Ram Mahajan, Ashish Verma and 2 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Zenio Biotech?
Zenio Biotech has a workforce of 0 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zenio Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zenio Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
